Opendata, web and dolomites

VADEMA SIGNED

Doctoral Industrial School for Vaccine Design through Structural Mass Spectrometry

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 VADEMA project word cloud

Explore the words cloud of the VADEMA project. It provides you a very rough idea of what is the project "VADEMA" about.

combined    killed    bearing    epitopes    membrane    form    structural    previously    industrial    trained    leaders    host    consisting    discovered    opened    empirical    good    raised    multiple    native    group    innovative    threatening    attenuated    accessible    efficient    conformation    antigens    microorganisms    life    forms    courses    academic    dynamics    led    training    devastating    antigen    platform    purified    spectrometry    observation    receive    degree    soluble    grow    alternative    rational    human    phd    technologies    components    complemented    impossible    dna    successful    efforts    humoral    parts    reverse    infections    protective    powerful    students    portions    live    broadly    respective    efficacious    strategy    vaccinology    opportunity    compare    science    mass    possibility    immune    vaccines    immunology    outcome    occasion    experimental    recombinant    decades    immunity    basic    diseases    glycoconjugation    designing    applicative    spread    despite   

Project "VADEMA" data sheet

The following table provides information about the project.

Coordinator
GLAXOSMITHKLINE VACCINES SRL 

Organization address
address: VIA FIORENTINA 1
city: SIENA
postcode: 53100
website: www.novartis.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.vadema.eu/
 Total cost 1˙096˙286 €
 EC max contribution 1˙096˙286 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2015
 Funding Scheme MSCA-ITN-EID
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GLAXOSMITHKLINE VACCINES SRL IT (SIENA) coordinator 516˙122.00
2    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 580˙163.00

Map

 Project objective

Vaccines discovered from empirical approaches and consisting in killed, live-attenuated microorganisms or purified components have led to the successful control of many devastating diseases. Several novel technologies, such as recombinant DNA technology, glycoconjugation, reverse vaccinology have opened the possibility of designing vaccines previously considered impossible to make. Despite decades of efforts, vaccines have not yet been developed against several of the most life-threatening infections. Based on the observation that an efficacious immune response only require protective epitopes, structural vaccinology combined with human immunology are therefore rapidly emerging as a powerful alternative strategy for the rational design of vaccines bearing multiple protective epitopes and offering the opportunity of developing broadly effective immunity. The proposal is focused on the development of a Structural Mass Spectrometry platform and its application to compare conformation and dynamics of antigens in their native states (membrane) with their recombinant soluble forms (vaccines) and to get a better understanding of the humoral response raised against the two forms. The outcome of such studies will be to identify antigen portions accessible to the host immune system and those epitopes that can be recognized in the native form of the antigens to design efficient vaccines. Structural Mass Spectrometry is a very new science in Europe and the proposal represents the unique opportunity for 4 PhD students to be trained by an academic and an industrial group, leaders in respective parts of the field. The program will be complemented with a number of training courses. The students will receive a PhD degree in structural mass spectrometry applied to vaccinology. It represents a good occasion to spread this technology in Europe and good opportunities for students that are willing to grow both in basic science as well as innovative and applicative experimental research.

 Deliverables

List of deliverables.
Recruitment Other 2019-03-20 15:38:37
Supervisory Board Other 2019-03-25 10:34:34

Take a look to the deliverables list in detail:  detailed list of VADEMA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VADEMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VADEMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More  

DESIGN-EID (2020)

Defect Simulation and Material Growth of III-V Nanostructures- European Industrial Doctorate Program

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More